Please login to the form below

Not currently logged in
Email:
Password:

CicloMulsion

This page shows the latest CicloMulsion news and features for those working in and with pharma, biotech and healthcare.

Sanofi licenses cardiovascular therapy in South Korea

Sanofi licenses cardiovascular therapy in South Korea

The deal - signed by Sanofi's Asian subsidiary and covering only the South Korean market - covers a new formulation of cyclophilin inhibitor cyclosporine A - called CicloMulsion - that is in phase III ... NeuroVive's chief executive Mikael Brönnegård

Latest news

  • inVentiv extends collaboration with NeuroVive inVentiv extends collaboration with NeuroVive

    The new deal will see consultancy firm InVentiv assist NeuroVive with the global commercialisation of its lead product, CicloMulsion, which is currently in phase III trials to determine its effectiveness in ... NeuroVive and inVentiv are already

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during November 2012 Pharma deals during November 2012

    8. Sihuan Pharmaceutical / NeuroVive Pharmaceutical. Collaboration agreement. CicloMulsion / NeuroSTAT to treat heart reperfusion / traumatic brain injuries. ... Canadian research facility.  South Korea market.  Pursuant to the collaboration agreement,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics